Sarcoma Awareness Month: Partnering to Provide Optimal Outcomes With Joseph Kalis, PharmD, BCOP, and Richard Riedel, MD
Expert Perspectives · Lyn Brook · 2024-07-29
In honor of Sarcoma Cancer Awareness Month in July, Oncology Data Advisor Editorial Board members Joseph Kalis, PharmD, BCOP, Ambulatory Oncology Clinical Pharmacy Specialist at the University of Colorado Health, and Richard Riedel, MD, an Associate Professor in the Division of Medical Oncology at Duke University Medical Center, sat down to discuss all things sarcoma, including:
- An overview of what sarcoma is and the many subtypes it includes
- How common sarcoma is and how often it presents
- Warning signs of sarcoma that both individuals and clinicians should look out for
- Recent advances in sarcoma research and treatment and efforts to combat the slower pace of research compared with other cancers
- Upcoming clinical trials and research to watch for and look forward to
- Messages for patients and clinicians in light of Sarcoma Awareness Month
- And more!
About Dr. Riedel and Dr. Kalis
Richard Riedel, MD, is an Associate Professor in the Division of Medical Oncology at Duke University Medical Center and the Associate Director of Clinical and Translational Research for the Duke Sarcoma Program. His clinical practice is dedicated to the care of patients with bone and soft tissue sarcoma, and his research interests lie in identifying novel therapies for these patients. Dr. Riedel is a member of the National Comprehensive Cancer Network (NCCN) Soft Tissue Sarcoma Guidelines Panel member and the NCCN Gastrointestinal Stromal Tumor (GIST) Guidelines Panel, and he is active in educational initiatives for sarcoma treatment.
Joseph Kalis, PharmD, BCOP, is an Ambulatory Oncology Clinical Pharmacy Specialist at the University of Colorado Health. In this position, he educates patients about their chemotherapy and immunotherapy treatments, reviews treatment plans and dose adjustments, and assists with supportive care. Dr. Kalis’ professional interests include multiple myeloma and hematologic malignancies. He enjoys teaching learners from all walks of life. Dr. Kalis has spoken extensively for continuing education programs, along with various peer-reviewed papers on oncology and pharmacy.